Drugs / tumor neoantigen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04087252 | Sep 2019 → Oct 2021 | cancer | Henan Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tumor neoantigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04087252 ↗ |
| Modality | Vaccine | “An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment” NCT04087252 ↗ |